​How do you turn a promising technology into a viable business opportunity? In this session, experts will discuss how to identify the right target market from a technology-driven perspective and evaluate the competitive landscape. The conversation will explore practical frameworks for assessing market need, positioning innovations, and understanding existing players shaping the field. This panel is designed to give early-stage founders and scientists insight into how successful biotech ventures define and validate their market opportunity.

​Panelists:

​David Crean

​Marisa Elliott

​Phong Tran

​Venkatramana Pegadaraju

​About the Host:​

​​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.

​​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!

​​Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma

​​Philanthropic Support: Lyda Hill Philanthropies

​​Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout

​​In-Kind Support: AcademicLabs, Lens.org, SynBioBeta